通过反应诱导的自我组装来治疗牙周炎的动态共价性产药纳米网络
Haoyue Wu1,2,3, Yong Liu3,4, Yumeng Wang3,5
1Department of International VIP Dental Clinic, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin 300041, China.
ACS nano
|December 11, 2024
概括
新的动态共价纳米网络 (dcNNWs) 通过消除生物膜,减少炎症和促进骨修复,有效治疗牙周炎. 这种创新的药物组合疗法为牙周炎管理提供了有前途的解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 牙周病学 牙周病学
背景情况:
- 牙周炎涉及菌生物膜,炎症和骨质损失,需要先进的治疗策略.
- 目前的治疗方法往往缺乏针对牙周炎的各个方面进行全面的治疗.
研究的目的:
- 开发和评估用于协同性牙周炎治疗的动态共价纳米网络 (dcNNWs).
- 评估dcNNWs在生物膜根除,抗炎和骨再生方面的有效性.
主要方法:
- 通过一,四组分反应诱导的自我组装合成dcNNWs.
- 纳入多氨基,2-甲基乙酸,表甲基酸和阿伦德罗酸.
- 在鼠标模型中对牙周炎的评估,评估生物膜抑制,免疫反应调节和骨质生成.
主要成果:
- dcNNWs表现出强大的生物粘合性和有效的预防/消除致病生物膜.
- 这些纳米网络吸收了与病原体相关的分子模式,并清除了反应性氧物种,减少了炎症.
- 释放的成分 (多和阿伦德罗酸盐) 显著减轻了炎症并增强了骨质生成.
结论:
- dcNNWs在对抗牙周炎,解决生物膜,炎症和骨吸收方面表现出协同作用.
- dcNNWs的简单合成和生物相容性构成了转化治疗方法.
- 这种纳米网络策略为有效的牙周炎管理提供了一个有希望的解决方案.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...


